Telesis Bio, Inc.
TBIO
$0.42
$0.1240.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.32% | -17.08% | 20.35% | 18.64% | 43.44% |
| Total Depreciation and Amortization | 6.49% | 16.73% | -5.35% | 11.37% | 18.31% |
| Total Amortization of Deferred Charges | -76.51% | 72.32% | 26.03% | 35.48% | 40.70% |
| Total Other Non-Cash Items | 231.74% | 301.41% | 212.43% | 247.59% | 21.20% |
| Change in Net Operating Assets | -202.23% | 110.41% | 111.28% | -368.61% | -224.02% |
| Cash from Operations | 46.91% | 61.10% | 39.63% | 10.50% | 27.54% |
| Capital Expenditure | 38.10% | 49.01% | 81.51% | 82.18% | 74.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 464.43% | -111.69% | -109.86% | 9.03% | 73.61% |
| Cash from Investing | 2,316.92% | -112.48% | -92.61% | 68.01% | 97.61% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -33,954.24% | -0.09% | 0.05% | -0.09% | 99.61% |
| Issuance of Common Stock | -80.98% | -63.19% | -88.33% | -88.28% | -97.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,234.56% | -48.27% | -48.27% | -48.27% | 98.54% |
| Cash from Financing | -157.00% | -149.17% | 160.62% | 156.43% | 508.48% |
| Foreign Exchange rate Adjustments | 168.75% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.65% | -247.18% | -63.65% | 44.75% | 91.35% |
